1 / 9

IV BRIEFING: Emergency Preparedness Coordinating Council

Learn about the current issues and shortages impacting IV fluids, nutritional products, and medication delivery, and discover strategies to manage inventory and ensure patient care. Stay updated on market dynamics and engage in advocacy efforts to address the situation.

mkeith
Download Presentation

IV BRIEFING: Emergency Preparedness Coordinating Council

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IV BRIEFING: Emergency Preparedness Coordinating Council January 18, 2018

  2. IV fluids Issues Product lines impacted IV fluids (sodium chloride, dextrose, lactated ringers) Nutritional products (amino acids) Medication delivery (mini-bags, compounding bags) Large-volume irrigation fluids in bags Evacuated containers • Product shortages and allocations are expected to continue for the next several months • At a minimum, the next several weeks are critical, as manufacturing plants come back online • Inventories are expected to begin to recover but are fragile • Product availability changes from week to week and must be closely managed

  3. IV Market Dynamics IV inventory levels remain very tight related to • market consolidation • quality controls and FDA requirements • recent natural disasters • Puerto Rico (Hurricane Maria) – Baxter – mini-bags and amino acids • Mexico (earthquake) - Baxter sets • California (wild fires) – Braun – all products - logistics • planned plant maintenance resulted in a recent two-week shutdown (Braun) • Baxter plant maintenance shutdown deferred to Spring • production lines being shifted to meet critical demand • creates other temporary shortages (Braun and Baxter) • product allocations by manufacturers to committed customers in order to protect/manage inventory • flu is now widespread (U.S. and NYS)

  4. NYS Flu Report Source: health.ny.gov

  5. NYS Flu Report Source: health.ny.gov

  6. U.S. Flu Report Source: cdc.gov

  7. Key Activities • Regular updates and communications to C-suite/Supply Chain/Rx • IV education and knowledge-sharing forum • Market overview • Conservation and Supply Chain strategies • Best practice networking forum • Advocacy efforts – FDA Office of Drug Shortages and Congress • Regular meeting with FDA • Letters to the FDA • Create awareness of current shortages and impact • Support for importation of product that meets U.S. standards (Baxter=Ireland, Australia) • Accelerated review/approval • Weekly status updates to monitor situation and provide member feedback

  8. What can you do? Hospitals are strongly advised to • develop proactive communication and education to leadership, nursing, medical staff, etc. • create conservation strategies where clinically appropriate • develop alternative clinical therapies/approaches and substitute products • Order full allocations • implement centralized inventory control methods for critical products • hold regular meetings to review IV needs/delivery projections to develop/implement contingency plans. Meetings should include the following: • Hospital (Supply Chain, Rx, Nursing, etc.) • Manufacturers • Distributors

  9. Questions Jay Fligstein Sr. Vice President Acurity, Inc. O: (212) 258-5316 |C: (646) 831-1493 jfligstein@acurity.com www.acurity.com

More Related